Social Media Site Could Help FDA Track Adverse Events
FDA-pharma partnership could improve data quality and increase use as industry continues to struggle to incorporate social media into pharmacovigilance.
You may also be interested in...
Agency and industry also decide to drop research into using social media to enhance post-market safety monitoring.
Growth of post-market surveillance system also may require more resources.
Teleconference between Google and FDA signals the internet search giant could have a way to improve adverse-event detection. The agency calls the talk “a high-level, general discussion” of Google’s capabilities.